Sat.Dec 30, 2023

article thumbnail

Biopharma dealmaking: predictions for 2024

European Pharmaceutical Review

The past 12 months has seen significant growth in global mergers and acquisitions (M&A) within the biopharma sector. This activity is expected to continue in 2024, with increasing need for biopharma to access innovation through collaboration and dealmaking to offset looming patent challenges. “In 2023, total life sciences deal value increased by 34 percent to $191 billion.

Biopharma 105
article thumbnail

From Budgetary Bummer to Sales Bonanza: Your 2024 Success Odyssey Starts Now

Contrarian Sales Techniques

2023 is on its last legs, and you're staring down the barrel of a fresh, blank calendar. Is it excitement that bubbles in your stomach, or dread? If you're a salesperson, the answer might be a bit of both. After all, a new year brings new opportunities, but also new challenges. The question is: are you ready to tackle them? If not, don't worry. This blog post is your road map to crushing your sales goals in 2024, even if the economic weather looks stormy.

Sales 52
article thumbnail

Top 5 Pharmacy Times Specialty Pharmacy Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read specialty pharmacy-related articles on Pharmacy Times in 2023.

52